Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ET
Company Participants
Alexa Huerta - Senior Director, Investor Relations
Keith Valentine - President and Chief Executive Officer
John Bostjancic - Chief Financial Officer
Jon Serbousek - Director, Executive Chairman of the Board
Doug Rice - Former Chief Financial Officer
Conference Call Participants
Mathew Blackman - Stifel
Jeffrey Cohen - Ladenburg Thalmann
Dave Turkaly - JMP Securities
Operator
Good afternoon and welcome to Orthofix Medical’s Q4 and Full-Year 2022 Earnings Call. All participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Alexa Huerta, Senior Director of Investor Relations. Thank you. Please go ahead.
Alexa Huerta
Thank you, operator, and good afternoon everyone. Welcome to the Orthofix fourth quarter 2022 earnings call. Joining me on the call today are President and Chief Executive Officer, Keith Valentine; and Chief Financial Officer, John Bostjancic; as well as our Executive Chairman of the Board and Orthofix’s Former Chief Executive Officer, Jon Serbousek; and Former Chief Financial Officer, Doug Rice.
During this call, we will be making forward-looking statements that involve risks and uncertainties. All statements other than those of historical facts are forward-looking statements, including any financial guidance we provide and any statements about our plans, beliefs, strategies, expectations, goals, or objectives. Investors are cautioned not to place undue reliance on such forward-looking statements as there is no assurance that the matter contained in such statements will occur.
The forward-looking statements we will make on today's call are based on our beliefs and expectations as of today, March 6, 2023. We do not undertake any obligation to revise or update such forward-looking statements. Some factors that could cause actual results to be materially different from the forward-looking statements made by us on the call include the risk factors disclosed under the heading Risk Factors in our Form 10-K for the year ended December 31, 2022 filed this afternoon March 6, 2023, as well as additional SEC filings we make in the future. If you need copies of these documents, please contact my office at Orthofix in Lewisville, Texas.
In addition, on today's call, we will refer to various non-GAAP financial measures. We believe that in order to properly understand our short-term and long-term financial trends, investors may wish to review these matters as a supplement to the financial measures determined in accordance with U.S. GAAP. Please refer to today's press release announcing our fourth quarter and full-year 2022 results for reconciliations of these non-GAAP financial measures to our U.S. GAAP financial results.